GlassScriptPhysician profile
Lingaiah Janumpally
NPI 1003892316
$8,725.06
in general payments reported to CMS, 2019-2025
59 companies · $2,699 in 2025
The $2,699 reported for 2025 was more than what 77% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2020: $149 · 2021: $130 · 2022: $1,551 · 2023: $1,222 · 2024: $1,993 · 2025: $2,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,773 · Education: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,773.02 |
| Education | $140.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $905.05 | 2019-2025 | Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $591.78 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $515.75 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Ucb, INC. | $501.37 | 2019-2025 | Rystiggo, Briviact, Nayzilam |
| Abbvie INC. | $471.33 | 2021-2025 | |
| Sk Life Science, INC. | $432.15 | 2023-2025 | |
| Eisai INC. | $431.23 | 2019-2025 | |
| Argenx US, INC. | $420.24 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Amgen INC. | $366.23 | 2019-2025 | Uplizna |
| Lilly USA, LLC | $342.75 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Celgene Corporation | $315.63 | 2021-2023 | Zeposia |
| Csl Behring | $279.19 | 2022-2025 | Hizentra |
| Lundbeck LLC | $193.65 | 2022-2025 | Vyepti, Rexulti |
| Alexion Pharmaceuticals, INC. | $193.05 | 2019-2025 | Ultomiris, Soliris |
| Octapharma USA, INC. | $175.07 | 2022-2025 | Panzyga |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lingaiah Janumpally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.